SynCore Biotechnology Co.,Ltd announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 1.276 million compared to TWD 1.658 million a year ago. Operating loss was TWD 83.170 million compared to TWD 109.369 million a year ago. Net loss was TWD 88.244 million compared to TWD 109.738 million a year ago. Basic loss per share from continuing operations was TWD 0.77 compared to TWD 1.08 a year ago. For the half year, sales was TWD 2.589 million compared to TWD 3.740 million a year ago. Operating loss was TWD 156.902 million compared to TWD 194.547 million a year ago. Net loss was TWD 159.809 million compared to TWD 194.270 million a year ago. Basic loss per share from continuing operations was TWD 1.42 compared to TWD 1.91 a year ago.